The horror-comedy, led by Ayushmann Khurrana and Rashmika Mandanna, has now entered the final stretch of its theatrical journey, maintaining a faint but consistent presence in smaller towns and single screens.
Day 19 Estimate & Tally
On Day 19, Thamma added an estimated ₹0.07 crore to its total, taking the India net collection to approximately ₹124.15 crore. The film’s late-run figures remain subdued, as expected, but its slow tapering suggests that the movie still commands limited traction in Tier-2 and Tier-3 centres. Multiplex circuits, especially in major metros, have nearly phased it out, with most screens now dedicated to newer releases.
The Late-Run Picture
The Day 19 figure aligns with the steady downward curve seen over the past few days. After earning around ₹0.11 crore on Day 16, ₹0.09 crore on Day 17, and roughly ₹0.08–0.10 crore on Day 18, Thamma continues to show predictable declines rather than sharp drops — a hallmark of a film settling into its end-of-run rhythm. This sustained trickle of collections underscores the film’s ability to hold on in smaller territories even as its urban footprint fades.
Why It Still Matters
* The “Maddock Horror Comedy Universe” branding has ensured a long shelf life beyond the initial hype.
* The film’s genre mix of humor and horror, supported by Khurrana’s relatable charm, continues to attract sporadic viewers seeking light entertainment.
* Crossing the ₹124 crore mark firmly positions Thamma among the higher-grossing mid-budget Hindi films of 2025, especially considering stiff competition and limited post-week-two promotions.
Final Run Projection
At this pace, Thamma is on course to conclude its theatrical run with a final India net total between ₹125 and ₹126 crore. Unless it experiences a weekend surge in a few single-screen strongholds, the film will quietly conclude its journey within the next few days.
Conclusion
Thamma’s Day 19 performance reflects a film nearing its finish line but doing so with quiet resilience. It may no longer be a major box-office force. Yet, its ability to sustain beyond 19 days—amid multiple new releases—marks a respectable close for a horror-comedy that struck the right chord with its target audience.
